Giovanni carbotta

Dr. Giovanni carbotta

Department of Surgery
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2015 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
VCVito Cantisani
Vito Cantisani
HGHektor Grazhdani
Hektor Grazhdani
EDElena Drakonaki
Elena Drakonaki
VDVito D’aNdrea
Vito D’aNdrea
MSMattia Di Segni
Mattia Di Segni
FDFerdinando D’aMbrosio
Ferdinando D’aMbrosio
Thyroid nodules, with their high prevalence in the general population, represent a diagnostic challenge for clinicians. Ultrasound (US), although absolutely reliable in detecting thyroid nodules, is still not accurate enough to differentiate them into benign and malignant. A promising novel modality, US elastography, has been introduced in order to further increase US accuracy. The purpose of this review article is to assess the thyroid application of US strain elastography, also known as real-time elastography or quasistatic elastography. We provide a presentation of the technique, and of up-to-date literature, analyzing the most prominent results reported for thyroid nodules differentiation. The practical advantages and limitations of strain elastography are extensively discussed herein.

27 October 2017 in Frontiers in Endocrinology
Verified
Journal Article
Open access
EBEnke Baldini
Enke Baldini
TOTeresa Odorisio
Teresa Odorisio
Salvatore SorrentiSalvatore Sorrenti
Salvatore Sorrenti
ACAntonio Catania
Antonio Catania
FTFrancesco Tartaglia
Francesco Tartaglia
Salvatore UlisseSalvatore Ulisse
Salvatore Ulisse
Vitiligo represents the most common cause of acquired skin, hair and oral depigmentation, affecting 0.5-1% of the population worldwide. It is clinically characterized by the appearance of disfiguring circumscribed skin macules following melanocyte destruction by autoreactive cytotoxic T lymphocytes. Patients affected by vitiligo usually show a poorer quality of life and are more likely to suffer from depressive symptoms, particularly evident in dark-skinned individuals. Although vitiligo is a non-fatal disease, exposure of affected skin to UV light increases the chance of skin irritation and predisposes to skin cancer. In addition, vitiligo has been associated to other rare systemic disorders due to the presence of melanocytes in other body districts, such as in eyes, auditory, nervous and cardiac tissues, where melanocytes are thought to have roles different from that played in the skin. Several pathogenetic models have been proposed to explain vitiligo onset and progression, but clinical and experimental findings point mainly to the autoimmune hypothesis as the most qualified one. In this context, it is of relevance the strong association of vitiligo with other autoimmune diseases, in particular with autoimmune thyroid disorders, such as Hashimoto thyroiditis and Graves’ disease. In this review, after a brief overview of vitiligo and its pathogenesis, we will describe the clinical association between vitiligo and autoimmune thyroid disorders and discuss the possible underlying molecular mechanism(s).

15 June 2018 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
EBEnke Baldini
Enke Baldini
TOTeresa Odorisio
Teresa Odorisio
CTChiara Tuccilli
Chiara Tuccilli
SPSeverino Persechino
Severino Persechino
SSSalvatore Sorrenti
Salvatore Sorrenti
Salvatore UlisseSalvatore Ulisse
Salvatore Ulisse

19 July 2012 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
GGGiorgio Grani
Giorgio Grani
ACAnna Calvanese
Anna Calvanese
GCGiovanni carbotta
Giovanni carbotta
MDMimma D'Alessandri
Mimma D'Alessandri
ANAngela Nesca
Angela Nesca
AFAngela Fumarola
Angela Fumarola

Verified
Journal Article
Open access
PDF file
Salvatore UlisseSalvatore Ulisse
Salvatore Ulisse
CTChiara TUCCILLI
Chiara TUCCILLI
Salvatore SorrentiSalvatore Sorrenti
Salvatore Sorrenti
Alessandro AntonelliAlessandro Antonelli
Alessandro Antonelli
PFPoupak Fallahi
Poupak Fallahi
EBEnke Baldini
Enke Baldini
The new immunotherapy targeting the programmed cell death 1 (PD-1) receptor and its cognate ligand PD-L1 has renewed hopes of eradicating the most difficult human cancers to treat. Among these, there are the poorly differentiated and anaplastic thyroid cancers, unresponsive to all the therapies currently in use. In the present review we will summarize information regarding the expression of PD-L1 in the different thyroid cancer histotypes, its correlation with clinicopathological features, and its potential prognostic value. Then, we will evaluate the available data indicating the PD-1/PD-L1 axis as a promising target for thyroid cancer therapy.

19 February 2013 in BMC Clinical Pathology
Verified
Journal Article
Open access
PDF file
EBEnke Baldini
Enke Baldini
Salvatore SorrentiSalvatore Sorrenti
Salvatore Sorrenti
CGCira Rosaria Tiziana Di Gioia
Cira Rosaria Tiziana Di Gioia
CVCorrado De Vito
Corrado De Vito
Alessandro AntonelliAlessandro Antonelli
Alessandro Antonelli
Salvatore UlisseSalvatore Ulisse
Salvatore Ulisse
Measurement of thyroglobulin (Tg) protein in the washout of the needle used for fine needle aspiration biopsy cytology (FNAB-C) has been shown to increase the sensitivity of FNAB-C in identifying cervical lymph node (CLN) metastasis from well-differentiated thyroid cancer (TC). In this study, we evaluated whether routine measurement of Tg protein (FNAB-Tgp), Tg mRNA (FNAB-Tgm) and calcitonin (CT) mRNA (FNAB-CTm) in the FNAB washout of CLN increases the accuracy of FNAB-C in the diagnosis of suspicious metastatic CLN.